Additional Metadata
Persistent URL dx.doi.org/10.1016/S0140-6736(05)17701-0, hdl.handle.net/1765/57706
Journal The Lancet
Citation
Janssen, H.L.A, van Zonneveld, M, Senturk, H, Zeuzem, S, Akarca, U.S, Cakaloglu, Y, … Schalm, S.W. (2005). Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial. The Lancet, 365(9454), 123–129. doi:10.1016/S0140-6736(05)17701-0